[go: up one dir, main page]

AU2002352390A1 - Rosiglitazone citrate and its use as antidiabetic - Google Patents

Rosiglitazone citrate and its use as antidiabetic

Info

Publication number
AU2002352390A1
AU2002352390A1 AU2002352390A AU2002352390A AU2002352390A1 AU 2002352390 A1 AU2002352390 A1 AU 2002352390A1 AU 2002352390 A AU2002352390 A AU 2002352390A AU 2002352390 A AU2002352390 A AU 2002352390A AU 2002352390 A1 AU2002352390 A1 AU 2002352390A1
Authority
AU
Australia
Prior art keywords
rosiglitazone
antidiabetic
citrate
rosiglitazone citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352390A
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2002352390A1 publication Critical patent/AU2002352390A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002352390A 2001-12-13 2002-12-13 Rosiglitazone citrate and its use as antidiabetic Abandoned AU2002352390A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0129851.2 2001-12-13
GBGB0129851.2A GB0129851D0 (en) 2001-12-13 2001-12-13 Novel compounds
PCT/GB2002/005677 WO2003050115A1 (en) 2001-12-13 2002-12-13 Rosiglitazone citrate and its use as antidiabetic

Publications (1)

Publication Number Publication Date
AU2002352390A1 true AU2002352390A1 (en) 2003-06-23

Family

ID=9927567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352390A Abandoned AU2002352390A1 (en) 2001-12-13 2002-12-13 Rosiglitazone citrate and its use as antidiabetic

Country Status (3)

Country Link
AU (1) AU2002352390A1 (en)
GB (1) GB0129851D0 (en)
WO (1) WO2003050115A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047541A1 (en) * 2004-02-13 2006-01-25 Sandoz Ag PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates

Also Published As

Publication number Publication date
WO2003050115A1 (en) 2003-06-19
GB0129851D0 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002314744A1 (en) Thiazole and other heterocyclic ligands and use thereof
AU2001244618A1 (en) Substituted 1,3-thiazole compounds, their production and use
AU2003271498A1 (en) Coolant solutions and compositions comprising the sameitle
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
TWI315982B (en) Combinations comprising epothilones and pharmaceutical uses thereof
AU2002359694A1 (en) Compounds and methods
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2002255704A1 (en) Novel anti-adhesive compounds and uses thereof
AU2002352390A1 (en) Rosiglitazone citrate and its use as antidiabetic
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002306336A1 (en) Novel isoxazolopyridone derivatives and use thereof
AU2002228426A1 (en) Neurotonin and use thereof
HK1067325A (en) Combinations comprising epothilones and pharmaceutical uses thereof
AU2002256588A1 (en) Catalase-inactivating compounds and the use thereof
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AUPR904801A0 (en) Thiazole compound and pharmaceutical use thereof
AUPR874901A0 (en) Thiazole compound and pharmaceutical use thereof
AU2002322287A1 (en) Novel idolinones and uses thereof
AU2002312558A1 (en) Novel pyridopyrimidones and uses thereof
AU2002329446A1 (en) Composition and media
AU2001244831A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
AU2001244832A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase